Correlation Between Iovance Biotherapeutics and Hard To
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Hard To at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Hard To into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Hard to Treat, you can compare the effects of market volatilities on Iovance Biotherapeutics and Hard To and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Hard To. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Hard To.
Diversification Opportunities for Iovance Biotherapeutics and Hard To
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Iovance and Hard is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Hard to Treat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hard to Treat and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Hard To. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hard to Treat has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Hard To go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Hard To
If you would invest 0.00 in Hard to Treat on December 19, 2024 and sell it today you would earn a total of 0.00 from holding Hard to Treat or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 98.31% |
Values | Daily Returns |
Iovance Biotherapeutics vs. Hard to Treat
Performance |
Timeline |
Iovance Biotherapeutics |
Hard to Treat |
Iovance Biotherapeutics and Hard To Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iovance Biotherapeutics and Hard To
The main advantage of trading using opposite Iovance Biotherapeutics and Hard To positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Hard To can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hard To will offset losses from the drop in Hard To's long position.Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Hard To vs. American Scientf | Hard To vs. Ingen Technologies | Hard To vs. American Green Group | Hard To vs. Lifeline Biotechnologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |